Abstract:Background and purpose: Cerebral ischemia/reperfusion is associated with reactive oxygen species (ROS) generation, and NADPH oxidases are important sources of ROS. We hypothesized that NADPH oxidases mediate blood-brain barrier (BBB) disruption and contribute to tissue damage in ischemia/reperfusion. Methods: Ischemia was induced by filament occlusion of the middle cerebral artery in mice for 2 hours followed by reperfusion. BBB permeability was measured by Evans blue extravasation. Monolayer permeability was determined from transendothelial electrical resistance of cultured porcine brain capillary endothelial cells. Results: BBB permeability was increased in the ischemic hemisphere 1 hour after reperfusion. In NADPH oxidase-knockout (gp91phox(-/-)) mice, middle cerebral artery occlusion-induced BBB disruption and lesion volume were largely attenuated compared with those in wild-type mice. Inhibition of NADPH oxidase by apocynin prevented BBB damage. In porcine brain capillary endothelial cells, hypoxia/reoxygenation induced translocation of the NADPH oxidase activator Rac-1 to the membrane. In vivo inhibition of Rac-1 by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin or Clostridium difficile lethal toxin B also prevented the ischemia/reperfusion-induced BBB disruption. Stimulation of porcine brain capillary endothelial cells with H(2)O(2) increased permeability, an effect attenuated by inhibition of phosphatidyl inositol 3-kinase or c-Jun N-terminal kinase but not blockade of extracellular signal-regulated kinase-1/2 or p38 mitogen-activated protein kinase. Inhibition of Rho kinase completely prevented the ROS-induced increase in permeability and the ROS-induced polymerization of the actin cytoskeleton. Conclusions: Activation of Rac and subsequently of the gp91phox containing NADPH oxidase promotes cerebral ROS formation, which then leads to Rho kinase-mediated endothelial cell contraction and disruption of the BBB. Inhibition of NADPH oxidase is a promising approach to reduce brain injury after stroke.

Role of NADPH Oxidases in Oxidative Stress after Ischemic Stroke

NADPH oxidase and cerebral ischemia-reperfusion injury

Pathophysiology and Therapeutic Potential of NADPH Oxidases in Ischemic Stroke-Induced Oxidative Stress.

Role of NADPH Oxidases in Stroke Recovery

Oxidative Injury in Ischemic Stroke: A Focus on NADPH Oxidase 4

Targeting Nitrosative Stress as a Therapeutic Strategy for Neurovascular Protection in Brain Ischemia

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Foxo1-induced Mir-92B Down-Regulation Promotes Blood-Brain Barrier Damage after Ischaemic Stroke by Targeting NOX4

Targeting nitrosative stress for neurovascular protection: new implications in brain diseases.

Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress

Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2

Pathophysiology of Ischemic Stroke: Noncoding RNA Role in Oxidative Stress

Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review

NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke

The Role of Oxidative Stress in Acute Ischemic Stroke-Related Thrombosis

Oxidative Stress and Ischemic Stroke

Roles of Nitric Oxide in Brain Ischemia and Reperfusion

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders

NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets

Combined NADPH and the NOX Inhibitor Apocynin Provides Greater Anti-Inflammatory and Neuroprotective Effects in a Mouse Model of Stroke

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.